Mason Street Advisors, LLC Xencor Inc Transaction History

Mason Street Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$40.81 - $53.88 $874,354 - $1.15 Million	-21,425 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$36.63 - $47.63 $1,868 - $2,429	-51 Reduced 0.24%	21,425 $935,000
Q3 2020 Nov 13, 2020	BUY	$30.09 - $43.02 $85,967 - $122,908	2,857 Added 15.34%	21,476 $833,000
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $39,724 - $47,824	1,431 Added 8.33%	18,619 $603,000
Q4 2019 Feb 19, 2020	BUY	$32.75 - $41.43 $15,130 - $19,140	462 Added 2.76%	17,188 $591,000
Q3 2019 Nov 05, 2019	BUY	$33.73 - $46.27 $564,167 - $773,912	16,726 New	16,726 $564,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.42B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.